Anti-Dux4 antibody [E5-5] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal DUX4 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
DUX10, DUX4, Double homeobox protein 4, Double homeobox protein 10
- WB
Lab
Western blot - Anti-Dux4 antibody [E5-5] - BSA and Azide free (AB216893)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM /TBST The expression profile observed in HFF-1 is consistent with the literature (PMID : 30420784). Negative control : HFF-1 (PMID : 30420784) This data was developed using ab124699, the same antibody clone in a different buffer formulation.
Lanes 1 - 5:
Western blot - Anti-Dux4 antibody [E5-5] - BSA and Azide free (ab216893) at 1/1000 dilution
Lanes 1 - 5:
Western blot - Anti-Dux4 antibody [E5-5] (<a href='/en-us/products/primary-antibodies/dux4-antibody-e5-5-ab124699'>ab124699</a>) at 1/1000 dilution
Lane 1:
Human testis tissue lysate at 20 µg
Lane 2:
HFF-1 (Human Skin fibroblast) whole cell lysate at 20 µg
Lane 3:
293T (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
A549 (Human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
Exposure time: 60s
- WB
Unknown
Western blot - Anti-Dux4 antibody [E5-5] - BSA and Azide free (AB216893)
This data was developed using ab124699, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Dux4 antibody [E5-5] (<a href='/en-us/products/primary-antibodies/dux4-antibody-e5-5-ab124699'>ab124699</a>) at 1/1000 dilution
Lane 1:
Human testis lysate at 10 µg
Lane 2:
HT1080 (human fibrosarcoma cell line) cell lysate at 10 µg
Lane 3:
PC-3 (human prostate adenocarcinoma cell line) cell lysate at 10 µg
Lane 4:
HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 45 kDa,52 kDa
false
- WB
Lab
Western blot - Anti-Dux4 antibody [E5-5] - BSA and Azide free (AB216893)
This data was developed using ab124699, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Dux4 antibody [E5-5] (<a href='/en-us/products/primary-antibodies/dux4-antibody-e5-5-ab124699'>ab124699</a>) at 1/1000 dilution
Lane 1:
HT1080 (human fibrosarcoma cell line) whole cell lysate at 20 µg
Lane 2:
PC-3 (human prostate adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 3:
Saos-2 (human osteosarcoma cell line) whole cell lysate at 20 µg
Lane 4:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
Reactivity data
Product details
ab216893 is the carrier-free version of ab124699.
For details on the developement of this clone, please refer to Geng et al. Hybridoma (Larchmt). 2011 Apr; 30(2): 125–130. PMID: 21529284
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Dux4 regulates a wide range of genes associated with muscle differentiation and apoptosis. It is not typically part of a known protein complex but acts independently to influence gene activity. Its function as a transcription factor impacts muscle cell differentiation by activating various myogenic and apoptotic genes. This regulatory activity plays a major role in normal muscle function and development in embryos.
Pathways
Dux4 plays a significant role in the Wnt signaling and beta-catenin pathways. These pathways are important for tissue development and cellular proliferation. Dux4 interacts with proteins like beta-catenin to influence cell growth and differentiation. Inappropriate activation of these pathways due to Dux4 involvement can result in dysregulated cell growth impacting muscle tissue integrity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Stem cell research & therapy 16:179 PubMed40234972
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com